ArticleJAMA oncology2026

PDS0101 With Pembrolizumab in HPV16-Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Nonrandomized Clinical Trial.

Jared Weiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.